• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Cardiac PET Imaging of ATP Binding Cassette (ABC) Transporters: Opportunities and Challenges.三磷酸腺苷结合盒(ABC)转运蛋白的心脏正电子发射断层显像(PET):机遇与挑战
Pharmaceuticals (Basel). 2023 Dec 11;16(12):1715. doi: 10.3390/ph16121715.
2
PET and SPECT radiotracers to assess function and expression of ABC transporters in vivo.正电子发射断层扫描和单光子发射计算机断层扫描放射性示踪剂评估 ABC 转运体在体内的功能和表达。
Curr Drug Metab. 2011 Oct;12(8):774-92. doi: 10.2174/138920011798356980.
3
Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.对ABC转运蛋白ABCB1/MDR/ P-糖蛋白、ABCC2/MRP2和ABCG2/BCRP在结直肠癌病理生理学中的新认识。
World J Gastroenterol. 2015 Nov 7;21(41):11862-76. doi: 10.3748/wjg.v21.i41.11862.
4
Sunitinib (Sutent, SU11248), a small-molecule receptor tyrosine kinase inhibitor, blocks function of the ATP-binding cassette (ABC) transporters P-glycoprotein (ABCB1) and ABCG2.舒尼替尼(索坦,SU11248)是一种小分子受体酪氨酸激酶抑制剂,可阻断ATP结合盒(ABC)转运蛋白P-糖蛋白(ABCB1)和ABCG2的功能。
Drug Metab Dispos. 2009 Feb;37(2):359-65. doi: 10.1124/dmd.108.024612. Epub 2008 Oct 29.
5
PET imaging to assess the impact of P-glycoprotein on pulmonary drug delivery in rats.正电子发射断层扫描成像评估 P-糖蛋白对大鼠肺部药物传递的影响。
J Control Release. 2022 Feb;342:44-52. doi: 10.1016/j.jconrel.2021.12.031. Epub 2021 Dec 28.
6
Dissimilar Effect of P-Glycoprotein and Breast Cancer Resistance Protein Inhibition on the Distribution of Erlotinib to the Retina and Brain in Humans and Mice.P-糖蛋白和乳腺癌耐药蛋白抑制对厄洛替尼在人和小鼠视网膜和脑中分布的不同影响。
Mol Pharm. 2023 Nov 6;20(11):5877-5887. doi: 10.1021/acs.molpharmaceut.3c00715. Epub 2023 Oct 26.
7
PET Tracers for Imaging of ABC Transporters at the Blood-Brain Barrier: Principles and Strategies.用于血脑屏障处ABC转运蛋白成像的PET示踪剂:原理与策略
Curr Pharm Des. 2016;22(38):5779-5785. doi: 10.2174/1381612822666160810123634.
8
Pharmacophore modeling of nilotinib as an inhibitor of ATP-binding cassette drug transporters and BCR-ABL kinase using a three-dimensional quantitative structure-activity relationship approach.使用三维定量构效关系方法对尼罗替尼作为ATP结合盒式药物转运体和BCR-ABL激酶抑制剂进行药效团建模。
Mol Pharm. 2014 Jul 7;11(7):2313-22. doi: 10.1021/mp400762h. Epub 2014 Jun 5.
9
Impact of P-gp and BCRP on pulmonary drug disposition assessed by PET imaging in rats.利用 PET 成像技术评估大鼠肺部药物处置中 P-糖蛋白和乳腺癌耐药蛋白的作用。
J Control Release. 2022 Sep;349:109-117. doi: 10.1016/j.jconrel.2022.06.065. Epub 2022 Jul 8.
10
ATP-binding cassette transporters in the heart.心脏中的ATP结合盒转运蛋白
Trends Cardiovasc Med. 2006 Jan;16(1):7-15. doi: 10.1016/j.tcm.2005.10.001.

引用本文的文献

1
Exploratory Study of Sex Differences in P-Glycoprotein Function at the Blood-Brain Barrier.血脑屏障处P-糖蛋白功能性别差异的探索性研究
Clin Transl Sci. 2025 Apr;18(4):e70196. doi: 10.1111/cts.70196.
2
Decoding cardiovascular risks: analyzing type 2 diabetes mellitus and ASCVD gene expression.解码心血管风险:分析 2 型糖尿病和 ASCVD 基因表达。
Front Endocrinol (Lausanne). 2024 Apr 23;15:1383772. doi: 10.3389/fendo.2024.1383772. eCollection 2024.

本文引用的文献

1
Mechanism of multidrug resistance to chemotherapy mediated by P‑glycoprotein (Review).P-糖蛋白介导的多药耐药化疗机制(综述)。
Int J Oncol. 2023 Nov;63(5). doi: 10.3892/ijo.2023.5567. Epub 2023 Sep 1.
2
Quantification of P-glycoprotein function at the human blood-brain barrier using [F]MC225 and PET.采用 [F]MC225 和 PET 技术对人血脑屏障 P-糖蛋白功能进行定量分析。
Eur J Nucl Med Mol Imaging. 2023 Nov;50(13):3917-3927. doi: 10.1007/s00259-023-06363-5. Epub 2023 Aug 8.
3
Influence of P-glycoprotein on pulmonary disposition of the model substrate [C]metoclopramide assessed by PET imaging in rats.通过PET成像评估P-糖蛋白对模型底物[C]胃复安在大鼠肺部处置的影响。
Eur J Pharm Sci. 2023 Apr 1;183:106404. doi: 10.1016/j.ejps.2023.106404. Epub 2023 Feb 10.
4
Cardiotoxicity of Anti-Cancer Radiation Therapy: a Focus on Heart Failure.抗癌放射治疗的心脏毒性:聚焦心力衰竭。
Curr Heart Fail Rep. 2023 Feb;20(1):44-55. doi: 10.1007/s11897-023-00587-0. Epub 2023 Jan 24.
5
Nuclear medicine in the assessment and prevention of cancer therapy-related cardiotoxicity: prospects and proposal of use by the European Association of Nuclear Medicine (EANM).核医学在评估和预防癌症治疗相关的心脏毒性方面的应用:欧洲核医学协会(EANM)的应用前景和建议。
Eur J Nucl Med Mol Imaging. 2023 Feb;50(3):792-812. doi: 10.1007/s00259-022-05991-7. Epub 2022 Nov 5.
6
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).2022年欧洲心脏病学会(ESC)与欧洲血液学协会(EHA)、欧洲治疗放射学与肿瘤学协会(ESTRO)以及国际心脏肿瘤学会(IC-OS)合作制定的心脏肿瘤学指南。
Eur Heart J. 2022 Nov 1;43(41):4229-4361. doi: 10.1093/eurheartj/ehac244.
7
Role of in Cardiovascular Disease.(原文中“Role of in Cardiovascular Disease.”存在信息缺失,推测完整内容可能是“Role of [具体事物] in Cardiovascular Disease.” ,这里先按字面翻译为)[具体事物]在心血管疾病中的作用。
J Pers Med. 2022 Jun 20;12(6):1010. doi: 10.3390/jpm12061010.
8
Dose-response assessment of cerebral P-glycoprotein inhibition in vivo with [F]MC225 and PET.体内[F]MC225 和 PET 对脑 P-糖蛋白抑制的剂量反应评估。
J Control Release. 2022 Jul;347:500-507. doi: 10.1016/j.jconrel.2022.05.026. Epub 2022 May 20.
9
Concept development of an on-chip PET system.片上正电子发射断层扫描(PET)系统的概念开发。
EJNMMI Phys. 2022 May 19;9(1):38. doi: 10.1186/s40658-022-00467-x.
10
A New Versatile Platform for Assessment of Improved Cardiac Performance in Human-Engineered Heart Tissues.用于评估人类工程心脏组织中心脏功能改善的新型多功能平台。
J Pers Med. 2022 Feb 4;12(2):214. doi: 10.3390/jpm12020214.

三磷酸腺苷结合盒(ABC)转运蛋白的心脏正电子发射断层显像(PET):机遇与挑战

Cardiac PET Imaging of ATP Binding Cassette (ABC) Transporters: Opportunities and Challenges.

作者信息

Liu Wanling, Mossel Pascalle, Schwach Verena, Slart Riemer H J A, Luurtsema Gert

机构信息

Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.

Department of Applied Stem Cell Technologies, TechMed Centre, University of Twente, 7500 AE Enschede, The Netherlands.

出版信息

Pharmaceuticals (Basel). 2023 Dec 11;16(12):1715. doi: 10.3390/ph16121715.

DOI:10.3390/ph16121715
PMID:38139840
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10748140/
Abstract

Adenosine triphosphate binding cassette (ABC) transporters are a broad family of membrane protein complexes that use energy to transport molecules across cells and/or intracellular organelle lipid membranes. Many drugs used to treat cardiac diseases have an affinity for these transporters. Among others, P-glycoprotein (P-gp) plays an essential role in regulating drug concentrations that reach cardiac tissue and therefore contribute to cardiotoxicity. As a molecular imaging modality, positron emission tomography (PET) has emerged as a viable technique to investigate the function of P-gp in organs and tissues. Using PET imaging to evaluate cardiac P-gp function provides new insights for drug development and improves the precise use of medications. Nevertheless, information in this field is limited. In this review, we aim to examine the current applications of ABC transporter PET imaging and its tracers in the heart, with a specific emphasis on P-gp. Furthermore, the opportunities and challenges in this novel field will be discussed.

摘要

三磷酸腺苷结合盒(ABC)转运蛋白是一类广泛的膜蛋白复合物,它们利用能量将分子跨细胞和/或细胞内细胞器脂质膜进行转运。许多用于治疗心脏病的药物对这些转运蛋白具有亲和力。其中,P-糖蛋白(P-gp)在调节到达心脏组织的药物浓度方面起着至关重要的作用,因此会导致心脏毒性。作为一种分子成像方式,正电子发射断层扫描(PET)已成为研究器官和组织中P-gp功能的可行技术。利用PET成像评估心脏P-gp功能为药物开发提供了新的见解,并改善了药物的精准使用。然而,该领域的信息有限。在本综述中,我们旨在研究ABC转运蛋白PET成像及其示踪剂在心脏中的当前应用,特别强调P-gp。此外,还将讨论这一新兴领域的机遇和挑战。